Rapid Response to Larotrectinib (LOXO-101) in an Adult Chemotherapy-Naive Patients With Advanced Triple-Negative Secretory Breast Cancer Expressing ETV6-NTRK3 Fusion
Titel:
Rapid Response to Larotrectinib (LOXO-101) in an Adult Chemotherapy-Naive Patients With Advanced Triple-Negative Secretory Breast Cancer Expressing ETV6-NTRK3 Fusion
Auteur:
Landman, Yosef Ilouze, Maya Wein, Simon Neiman, Victoria Yerushalmi, Rinat Yakimov, Maxim Ku, Nora Schrock, Alexa B. Ali, Siraj Peled, Nir